The complementary and genomic DNA segments of the a-L-iduronidase gene from two Chinese mucopolysaccharidosis type I Hurler/Scheie (MPS IHIS) patients were amplified by polymerase chain reaction (PCR) and DNA sequencing was done to study their molecular lesions. Patient W3 has heterozygous mutations; the maternal allele has MII (G to A transition in the initiation codon ATG) and the paternal allele has Y343X (C to G transversion in exon 8 leading to in frame deletion of codons 325-343 from the mRNA owing to false splicing). Patient W2 is homozygous for mutation T364M (C to T transition in codon 364). The mutation was paternally inherited. A de novo deletion or gene conversion event may have resulted in apparent homozygosity for T364M. Expression of Y343X and T364M showed trace amounts of a-L-iduronidase activity comDepartment of pared to that of normal cDNA upon transBiology, National fection into COS-7 cells.
cosaminoglycans heparan sulphate and derma-T-R Wang tan sulphate. Loss or marked reduction of Correspondence to:
IDUA activity results in the autosomal recesDr Lee-Chen.
sive disease mucopolysaccharidosis type I Received 14 August 1996 (MPS I). MPS I involves a broad spectrum of Revised version accepted for clinical symptoms and can be divided into publication 9 April 1997 three clinical subtypes: Hurler, Hurler/Scheie, In this study, the molecular lesions of two 10 year old Chinese MPS IH/S patients with short stature, coarse face, and severe skeletal deformities were investigated. Both patients showed normal intelligence based on their good performance in school. Poly(A)+ RNA from the patients and a normal subject's skin fibroblast cells was prepared. Two pairs of primers that encompass IDUA cDNA sequences 76-906 and 857-2149 (table 1) , respectively, were used for PCR amplification on reverse transcribed cDNA. The amplified cDNA fragments were subcloned and sequenced by automated online DNA Sequencer. The results are summarised in table 2. In patient W3, one IDUA allele has M1I (a G to A transition in initiation codon) and an in frame deletion of the whole of exon 2, whereas the other allele has Y343X (an in frame deletion of nt 1061-1117 in exon 8). Patient W3 is heterozygous for M1I ( fig 1, lane 2) . The mutation MII also appeared in the patient's mother ( fig 1, lane 3) . The deleted exon 2 in MlI was the result of alternative splicing since MII appeared in the PCR amplified product containing exons 1-2 (data not shown). With MlI and deleted exon 2, the expressed IDUA protein has a deletion of N-terminal 132 residues that constitutes signal peptide. It is possible that this alteration prevents correct cotranslational transport of the protein into the endoplasmic reticulum and its further processing and transport to the lysosome. The recurrent Y343X was the result of a C to G transversion at nt 1117 leading to an in frame deletion of 19 residues in exon 8.7 Patient W3 is heterozygous for Y343X (fig 1, lane 5) . The mutation Y343X has been inherited from patient W3's father (fig 1, lane 4) . Expression of Y343X in COS-7 cells showed retention of a very low level of IDUA activity (table 3) . (fig 1, lane 7) , whereas the mother has no T364M (fig 1, lane 9) . The and V454I between the patient and the mother suggest the possibility of hemizygosity of this region of the IDUA gene in the patient. Alternatively, a double stranded break'4 gene conversion event might have resulted in homozygosity for T364M.
In conclusion, we have identified novel mutations in the IDUA gene in two Chinese MPS IH/S patients. The new missense mutations expand the heterogeneous spectrum of MPS I. Further characterisation of mutant alleles will provide a useful tool for diagnosis, counselling, and assessment of experimental protocols for MPS I syndrome.
